Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Review of the Current Knowledge

Kholoud Alawi Ghamri

Abstract

The vaccination process in most countries is expediting, and the world is moving into the terminal stage of the third wave of COVID-19. Many articles have been published on COVID-19 and pregnancy addressing the different features of the disease in this population. Therefore, the present study aims to aims to explore the salient features of COVID-19 in pregnancy and how it has affected maternal mortality and morbidity as published in the literature. Articles were searched using MeSH words in PubMed, Medline, Google Scholar, and Scopus from 20th May 2021 to 24th May 2021. Fever, cough, fatigue, and dyspnea were the most commonly reported presentation in these females; the disease severity ranged from mild to moderate in most females and moderate to severe in patients with co-morbidities, especially obesity and asthma. Evidence of mother to fetus transmission is scarce, and intrauterine transmission of COVID-19 is not supported by evidence. Hospitalization with careful monitoring should be done in patients with lymphopenia, and class III obesity, and stringent adherence to the SOPs should be ensured for safe delivery in this pandemic.


How to cite:
Vancouver
Ghamri KA. Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Review of the Current Knowledge. Int J Pharm Res Allied Sci. 2022;11(2):92-9. https://doi.org/10.51847/bqWZBpBD5U
APA
Ghamri, K. A. (2022). Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Review of the Current Knowledge. International Journal Of Pharmaceutical Research And Allied Sciences, 11(2),92-99. https://doi.org/10.51847/bqWZBpBD5U